Sort
48,018 grants matching “immunotherapy”
Potent Antibody Protection Against P. falciparum and P. vivax Malaria
$807,330Brandon James Dekosky · Massachusetts General Hospital · R01 · FY2025 · AI
Targeting PD-1 Pathway for Functional Cure of AIDS
$807,098Rama Rao Amara · Emory University · R37 · FY2023 · AI
Lymphatic control of germinal centers
$806,693Amanda W. Lund · New York University School Of Medicine · R01 · FY2025 · AI
Analysis of beta cell death in Type 1 diabetes
$806,617Kevan C Herold · Yale University · DP3 · FY2013 · DK
Preclinical studies of PG70 LEAPS peptide vaccines for rheumatoid arthritis
$806,505Daniel Hill Zimmerman · Cel-Sci Corporation · R44 · FY2017 · AR
Defining Protective IgGs to Food Allergy
$806,466Robert McCullough Anthony · Massachusetts General Hospital · R01 · FY2025 · AI
Vaccine and Drug Combination Therapy for Human Cancers
$806,457James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Vaccine and radiation for the therapy of human cancers
$806,457James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Comprehensive antigenic mapping of the human anti-peanut IgE antibody response
$806,277Scott Alan Smith · Vanderbilt University Medical Center · R01 · FY2023 · AI
Spatial omics to understanding HBV control in people with HIV coinfection
$806,208Robert E Schwartz · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · AI
Attenuating Inflammation to Restore GI Tract Integrity and Reduce Viral Reservoirs During cART
$806,014Jacob D Estes · Oregon Health & Science University · R01 · FY2019 · DK
Molecular Imaging of Novel Immuno-therapy and Targeted Therapies for Malignant...
$805,497Antoni Ribas · University Of California Los Angeles · P50 · FY2010 · CA
Immunologic and Antigenic Drivers of Immune Checkpoint Inhibitor-Associated Myocarditis
$805,488Justin M Balko · Vanderbilt University Medical Center · R01 · FY2025 · HL
Epigenetic Regulation of Normal and Pathologic CTCF Functions by BORIS
$804,869Victor Lobanenkov · Niaid Extramural Activities · Z01 · FY2007 · AI
Immunotherapy of low grade lymphoid malignancies
$804,816Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
Determinants of oral anaphylaxis to food
$804,775Stephanie Caroline Eisenbarth · Northwestern University At Chicago · R01 · FY2023 · AI
Targeting the immunosuppressive tumor microenvironment to enhance efficacy of radiotherapy and immuno-radiotherapy for oral cancer
$804,594Andrew Sikora · Baylor College Of Medicine · U01 · FY2018 · DE
Characterization and Enhancement of Anti-Tumor Immune Responses in Head and Neck Cancer
$804,578Clint Allen · National Institute On Deafness And Other Communication Disorders · ZIA · FY2016 · DC
ePACE: automation platforms for adaptable and scalable continuous evolution of biomolecules with therapeutic potential
$804,366Ahmad Samir Khalil · Boston University (Charles River Campus) · R01 · FY2024 · EB
Development of Salmonella for cancer therapeutics
$804,278Olivia Steele-Mortimer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
$804,206Roland K Strong · Fred Hutchinson Cancer Center · R01 · FY2023 · AI
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
$804,206Roland K Strong · Fred Hutchinson Cancer Center · R01 · FY2024 · AI
PEDIATRIC AIDS CLINICAL TRIAL UNIT
$804,182Univ Of Massachusetts Med Sch Worcester · U01 · FY2000 · AI
Novel Interventions Against HPV-associated Neoplasia
$803,955Paul F Lambert · University Of Wisconsin-Madison · U01 · FY2010 · CA
Discovery of Drugs, Targets, and Target Strategies for Immunotherapy of CLL
$803,614Christoph Rader · Basic Sciences · Z01 · FY2007 · CA